Aravive, Inc.
ARAVNASDAQHealthcare
$0.04
$-0.01(-13.39%)
Market Cap$2949860
P/E Ratio—
52W High$2.46
52W Low$0.04
Aravive, Inc. (ARAV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ARAV · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2024Report Date: Mar 20, 2024EPS Actual
-$0.46
Est. -$0.08 · -475.0%
Revenue
—
Fiscal Period
Q1 FY2024
FY ends December
Report Date
Mar 20, 2024
After Market Close
▼ Miss EPS
ARAV reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q1 FY2024 | Mar 20, 2024 | -$0.08 | -$0.46 | -475.0% | — | — | — |
| ▲ Q4 FY2023 | Nov 9, 2023 | -$0.24 | -$0.10 | +58.3% | $0.00B | $0.00B | +451.2% |
| ▲ Q3 FY2023 | Aug 21, 2023 | -$0.30 | -$0.12 | +60.0% | $0.00B | $0.00B | +196.3% |
| ▲ Q2 FY2023 | May 10, 2023 | -$0.33 | -$0.22 | +33.3% | $0.00B | $0.00B | +255.0% |
| ▼ Q1 FY2023 | Mar 15, 2023 | -$0.33 | -$0.46 | -39.4% | $0.00B | $0.00B | +130.3% |
| ▲ Q4 FY2022 | Nov 10, 2022 | -$0.64 | -$0.51 | +20.3% | $0.00B | $0.00B | +409.9% |
| ▲ Q3 FY2022 | Aug 11, 2022 | -$0.62 | -$0.61 | +1.6% | $0.00B | $0.00B | +74.3% |
| ▼ Q2 FY2022 | May 12, 2022 | -$0.53 | -$0.62 | -17.0% | $0.00B | $0.00B | +29.6% |
Q1 FY2024
Mar 20, 2024Miss
EPS Actual
-$0.46
EPS Est.
-$0.08
EPS Surpr.
-475.0%
Revenue
—
Q4 FY2023
Nov 9, 2023Beat
EPS Actual
-$0.10
EPS Est.
-$0.24
EPS Surpr.
+58.3%
Revenue
$0.00B
Q3 FY2023
Aug 21, 2023Beat
EPS Actual
-$0.12
EPS Est.
-$0.30
EPS Surpr.
+60.0%
Revenue
$0.00B
Q2 FY2023
May 10, 2023Beat
EPS Actual
-$0.22
EPS Est.
-$0.33
EPS Surpr.
+33.3%
Revenue
$0.00B
Q1 FY2023
Mar 15, 2023Miss
EPS Actual
-$0.46
EPS Est.
-$0.33
EPS Surpr.
-39.4%
Revenue
$0.00B
Q4 FY2022
Nov 10, 2022Beat
EPS Actual
-$0.51
EPS Est.
-$0.64
EPS Surpr.
+20.3%
Revenue
$0.00B
Q3 FY2022
Aug 11, 2022Beat
EPS Actual
-$0.61
EPS Est.
-$0.62
EPS Surpr.
+1.6%
Revenue
$0.00B
Q2 FY2022
May 12, 2022Miss
EPS Actual
-$0.62
EPS Est.
-$0.53
EPS Surpr.
-17.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $2.06 | $1.54 | $1.28 | 0 |
| Q2 FY2024 | $1.79 | $1.34 | $1.12 | 0 |
| Q1 FY2024 | $2.10 | $1.58 | $1.31 | 1 |
| Q4 FY2023 | $-0.08 | $-0.06 | $-0.05 | 1 |
| Q3 FY2023 | $-0.16 | $-0.15 | $-0.05 | 2 |
| Q2 FY2023 | $1.59 | $1.19 | $0.99 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2024 | Mar 20, 2024 | -475.0% | $0.04 | — | — |
| ▲ Q4 FY2023 | Nov 9, 2023 | +58.3% | $0.14 | $0.13 | -9.60% |
| ▲ Q3 FY2023 | Aug 21, 2023 | +60.0% | $0.22 | $0.21 | -6.82% |
| ▲ Q2 FY2023 | May 10, 2023 | +33.3% | $1.66 | $1.69 | +1.81% |
| ▼ Q1 FY2023 | Mar 15, 2023 | -39.4% | $1.68 | $1.61 | -4.17% |
| ▲ Q4 FY2022 | Nov 10, 2022 | +20.3% | $1.35 | $1.55 | +14.81% |
| ▲ Q3 FY2022 | Aug 11, 2022 | +1.6% | $0.98 | $0.93 | -5.61% |
| ▼ Q2 FY2022 | May 12, 2022 | -17.0% | $1.15 | $1.12 | -2.61% |
Q1 FY2024—
Report Date
Mar 20, 2024
EPS Beat/Miss
-475.0%
Price Before
$0.04
Price After
—
Q4 FY2023-9.60%
Report Date
Nov 9, 2023
EPS Beat/Miss
+58.3%
Price Before
$0.14
Price After
$0.13
Q3 FY2023-6.82%
Report Date
Aug 21, 2023
EPS Beat/Miss
+60.0%
Price Before
$0.22
Price After
$0.21
Q2 FY2023+1.81%
Report Date
May 10, 2023
EPS Beat/Miss
+33.3%
Price Before
$1.66
Price After
$1.69
Q1 FY2023-4.17%
Report Date
Mar 15, 2023
EPS Beat/Miss
-39.4%
Price Before
$1.68
Price After
$1.61
Q4 FY2022+14.81%
Report Date
Nov 10, 2022
EPS Beat/Miss
+20.3%
Price Before
$1.35
Price After
$1.55
Q3 FY2022-5.61%
Report Date
Aug 11, 2022
EPS Beat/Miss
+1.6%
Price Before
$0.98
Price After
$0.93
Q2 FY2022-2.61%
Report Date
May 12, 2022
EPS Beat/Miss
-17.0%
Price Before
$1.15
Price After
$1.12
Avg Beat Reaction-1.08%
Avg Miss Reaction-3.39%
Beat Rate5 / 8 quarters
Largest Move+14.81% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ARAV ends December
Aravive, Inc. (ARAV) most recently reported earnings on March 20, 2024 for Q1 FY2024, posting EPS of $-0.46 — missing the analyst consensus of $-0.08 by -475.0%. The next ARAV earnings date is expected around September 1, 2026.
Each quarter, investors track ARAV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARAV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ARAV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ARAV earnings · 5 questionsAravive, Inc.'s next earnings report is expected around September 1, 2026. ARAV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARAV historically reports after market close (AMC).
ARAV earnings datewhen is ARAV earningsARAV next earnings datewhen does ARAV report earningsARAV earnings calendar
▸ Source: FMP · Aravive, Inc. SEC filings · US GAAP · Aravive, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026